Pediatrix Medical Group (NYSE:MD) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Pediatrix Medical Group, Inc. (NYSE:MD)’s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $20.17 and traded as high as $20.73. Pediatrix Medical Group shares last traded at $20.6090, with a volume of 1,286,465 shares trading hands.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on MD shares. Jefferies Financial Group raised shares of Pediatrix Medical Group to a “strong-buy” rating in a research note on Thursday, March 12th. Truist Financial decreased their price target on shares of Pediatrix Medical Group from $24.00 to $21.00 and set a “hold” rating for the company in a research note on Thursday, February 19th. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on shares of Pediatrix Medical Group in a report on Friday, February 20th. UBS Group cut their price objective on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 24th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $19.80.

Pediatrix Medical Group Stock Up 4.6%

The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.66 and a current ratio of 1.66. The stock’s 50 day simple moving average is $20.65 and its 200 day simple moving average is $20.17. The firm has a market cap of $1.71 billion, a P/E ratio of 10.62 and a beta of 0.79.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Thursday, February 19th. The company reported $0.50 earnings per share for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). The business had revenue of $493.77 million during the quarter, compared to the consensus estimate of $486.23 million. Pediatrix Medical Group had a net margin of 8.64% and a return on equity of 19.59%. The firm’s quarterly revenue was down 1.7% on a year-over-year basis. During the same period last year, the business posted $0.51 earnings per share. Research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds have recently added to or reduced their stakes in the stock. Y Intercept Hong Kong Ltd bought a new position in shares of Pediatrix Medical Group in the third quarter valued at approximately $513,000. Allianz Asset Management GmbH grew its holdings in Pediatrix Medical Group by 158.5% during the third quarter. Allianz Asset Management GmbH now owns 158,777 shares of the company’s stock worth $2,660,000 after buying an additional 97,365 shares in the last quarter. Dana Investment Advisors Inc. raised its position in Pediatrix Medical Group by 5.6% in the 3rd quarter. Dana Investment Advisors Inc. now owns 801,462 shares of the company’s stock valued at $13,424,000 after buying an additional 42,162 shares during the last quarter. Hsbc Holdings PLC lifted its stake in Pediatrix Medical Group by 226.6% during the 2nd quarter. Hsbc Holdings PLC now owns 111,997 shares of the company’s stock valued at $1,591,000 after acquiring an additional 77,704 shares in the last quarter. Finally, Edgestream Partners L.P. bought a new position in Pediatrix Medical Group during the 2nd quarter valued at $763,000. Institutional investors and hedge funds own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.